A great biotech stock for your portfolioMedMira’s RVF® Technology is at the center of our current and future success.
There are four rapid testing technologies currently used in building rapid tests and only two are patented.
In addition to being the fastest of these technologies, MedMira’s RVF® platform has a distinct competitive advantage of multiplexing, which increases efficiency and decreases the overall cost for customers.
Based on these unique capabilities, we have secured a number of high value contracts and regularly attract world-class collaborators. Testing applications for our products include public health programs, Voluntary Testing & Counselling Centers (VCTs), pharmacies, physician offices, immigration screening, occupational exposures, convenience care clinics, correctional facilities, and more.